IL1B and metabolic dysfunction-associated steatotic liver disease: The inhibition of macrophage activation, specifically M1 macrophages, by curcumin further resulted in a reduction of IL-1β and TNF-α expression, contributing to the alleviation of liver dysfunction and inflammation during NAFLD.